PT Diagnos Laboratorium Utama Tbk
IDX:DGNS.JK
246 (IDR) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) IDR.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 39,300.114 | 41,745.483 | 38,581.725 | 35,903.12 | 33,574.437 | 37,636.735 | 49,058.473 | 46,971.898 | 38,967.044 | 57,888.936 | 51,350.068 | 82,042.117 | 80,918.408 | 87,870.916 | 82,477.525 | 56,362.568 | 28,700.413 | 15,630.175 | 14,695.423 | 14,695.423 | 10,973.415 | 10,973.415 |
| Cost of Revenue
| 24,272.991 | 24,880.966 | 23,753.697 | 23,662.21 | 22,669.584 | 23,966.983 | 26,574.137 | 26,364.131 | 22,660.824 | 28,888.976 | 33,626.215 | 42,976.953 | 34,841.627 | 43,093.26 | 45,749.979 | 26,205.076 | 17,052.19 | 8,684.333 | 8,919.453 | 8,919.453 | 6,976.201 | 6,976.201 |
| Gross Profit
| 15,027.124 | 16,864.517 | 14,828.027 | 12,240.91 | 10,904.853 | 13,669.752 | 22,484.336 | 20,607.767 | 16,306.22 | 28,999.96 | 17,723.853 | 39,065.164 | 46,076.781 | 44,777.655 | 36,727.546 | 30,157.492 | 11,648.223 | 6,945.841 | 5,775.971 | 5,775.971 | 3,997.214 | 3,997.214 |
| Gross Profit Ratio
| 0.382 | 0.404 | 0.384 | 0.341 | 0.325 | 0.363 | 0.458 | 0.439 | 0.418 | 0.501 | 0.345 | 0.476 | 0.569 | 0.51 | 0.445 | 0.535 | 0.406 | 0.444 | 0.393 | 0.393 | 0.364 | 0.364 |
| Reseach & Development Expenses
| 45.225 | 235.207 | 30.406 | 26.114 | 192.524 | 0 | 145.347 | 171.762 | 152.893 | 116.169 | 61.395 | 2.401 | 96.461 | 32.771 | 593.36 | 0 | 402.81 | 402.81 | 81.282 | 81.282 | 131.663 | 131.663 |
| General & Administrative Expenses
| 0 | 15,141.512 | 16,283.609 | 14,955.583 | 15,683.165 | 16,752.713 | 17,867.661 | 17,154.425 | 15,359.115 | 14,945.689 | 17,142.001 | 11,451.874 | 10,435.889 | 13,117.091 | 6,240.249 | 4,256.178 | 1,702.965 | 4,057.833 | 1,351.537 | 1,351.537 | 1,226.536 | 1,226.536 |
| Selling & Marketing Expenses
| 0 | 2,940.735 | 3,398.322 | 2,156.996 | 1,723.895 | 2,465.449 | 4,598.779 | 2,543.41 | 2,738.231 | 3,113.119 | 4,048.099 | 2,398.084 | 3,252.641 | 3,379.198 | 1,006.454 | 235.053 | 422.808 | 309.758 | 393.649 | 393.649 | 148.947 | 148.947 |
| SG&A
| 15,102.015 | 15,961.244 | 17,462.03 | 15,112.055 | 15,546.532 | 17,349.834 | 20,836.077 | 17,765.179 | 13,793.454 | 17,572.463 | 21,149.715 | 13,215.925 | 14,618.863 | 16,944.852 | 6,023.897 | 5,004.242 | 2,576.984 | 4,888.306 | 1,970.89 | 1,970.89 | 1,375.483 | 1,375.483 |
| Other Expenses
| 0 | 0 | -147.944 | -0.1 | 0 | 0 | -48.521 | -8.653 | 0 | 0 | 0 | -21.079 | -383.854 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 15,147.24 | 16,196.451 | 17,640.38 | 15,138.269 | 15,546.532 | 17,349.834 | 21,029.945 | 17,945.595 | 13,946.346 | 17,688.632 | 21,149.715 | 13,237.004 | 15,002.717 | 16,977.623 | 5,801.45 | 4,938.505 | 2,875.763 | 4,888.306 | 2,044.089 | 2,044.089 | 1,407.381 | 1,407.381 |
| Operating Income
| -120.116 | 668.066 | -2,812.353 | -2,897.359 | -4,641.679 | -3,680.082 | 1,454.391 | 2,662.172 | 2,359.874 | 11,311.328 | -3,425.863 | 25,828.16 | 31,074.065 | 27,800.032 | 30,703.649 | 25,153.249 | 9,071.239 | 2,057.535 | 3,805.081 | 3,805.081 | 2,621.731 | 2,621.731 |
| Operating Income Ratio
| -0.003 | 0.016 | -0.073 | -0.081 | -0.138 | -0.098 | 0.03 | 0.057 | 0.061 | 0.195 | -0.067 | 0.315 | 0.384 | 0.316 | 0.372 | 0.446 | 0.316 | 0.132 | 0.259 | 0.259 | 0.239 | 0.239 |
| Total Other Income Expenses Net
| -48.805 | -450.223 | 53.605 | -117.388 | 278.034 | 244.42 | 92.473 | 86.043 | -286.644 | -346.168 | 1,182.496 | 249.578 | 371.315 | 199.089 | 222.447 | 65.737 | -408.899 | 110.12 | -73.2 | -73.2 | -31.898 | -31.898 |
| Income Before Tax
| -168.921 | 217.843 | -2,758.748 | -3,014.747 | -4,363.645 | -3,435.661 | 1,546.864 | 2,748.215 | 2,073.23 | 10,965.161 | -2,243.367 | 26,077.738 | 31,445.38 | 27,999.121 | 30,926.096 | 25,218.987 | 8,662.339 | 2,167.656 | 3,731.881 | 3,731.881 | 2,589.833 | 2,589.833 |
| Income Before Tax Ratio
| -0.004 | 0.005 | -0.072 | -0.084 | -0.13 | -0.091 | 0.032 | 0.059 | 0.053 | 0.189 | -0.044 | 0.318 | 0.389 | 0.319 | 0.375 | 0.447 | 0.302 | 0.139 | 0.254 | 0.254 | 0.236 | 0.236 |
| Income Tax Expense
| -1,108.966 | 0 | 246.335 | -102.455 | -90.469 | 29.593 | 1,041.773 | 1,016.389 | 46.147 | 2,564.27 | -2,571.476 | 8,194.385 | 7,148.52 | 6,203.937 | 5,988.162 | 5,671.267 | 2,025.178 | 603.932 | 1,071.824 | 1,071.824 | 612.595 | 612.595 |
| Net Income
| 940.044 | 217.843 | -3,005.083 | -2,912.292 | -4,273.176 | -3,465.254 | 505.091 | 1,731.827 | 2,027.083 | 8,400.89 | 328.109 | 17,883.352 | 24,296.86 | 21,795.184 | 24,937.935 | 19,547.719 | 6,637.161 | 1,563.724 | 2,660.058 | 2,660.058 | 1,977.238 | 1,977.238 |
| Net Income Ratio
| 0.024 | 0.005 | -0.078 | -0.081 | -0.127 | -0.092 | 0.01 | 0.037 | 0.052 | 0.145 | 0.006 | 0.218 | 0.3 | 0.248 | 0.302 | 0.347 | 0.231 | 0.1 | 0.181 | 0.181 | 0.18 | 0.18 |
| EPS
| 0.75 | 0.17 | -2.4 | -2.33 | -3.42 | -2.77 | 0.4 | 1.39 | 1.62 | 6.72 | 0.26 | 14.31 | 19.44 | 17.44 | 24.94 | 19.55 | 6.64 | 1.56 | 5.11 | 5.11 | 24.72 | 24.72 |
| EPS Diluted
| 0.75 | 0.17 | -2.4 | -2.33 | -3.42 | -2.77 | 0.4 | 1.39 | 1.62 | 6.72 | 0.26 | 14.31 | 19.44 | 17.44 | 24.94 | 19.55 | 6.64 | 1.56 | 5.11 | 5.11 | 24.72 | 24.72 |
| EBITDA
| 3,564.4 | 4,317.164 | 691.543 | 752.2 | -925.709 | 81.898 | 4,645.215 | 6,505.437 | 5,557.314 | 14,314.332 | -4.983 | 27,553.622 | 32,298.89 | 28,990.641 | 31,305.12 | 26,150.877 | 10,068.866 | 2,728.501 | 4,229.829 | 4,229.829 | 2,923.9 | 2,923.9 |
| EBITDA Ratio
| 0.091 | 0.103 | 0.018 | 0.021 | -0.028 | 0.002 | 0.095 | 0.138 | 0.143 | 0.247 | -0 | 0.336 | 0.399 | 0.33 | 0.38 | 0.464 | 0.351 | 0.175 | 0.288 | 0.288 | 0.266 | 0.266 |